InvestorsHub Logo

elichen

07/21/20 2:37 PM

#339173 RE: WeeZuhl #339169

wrt the MANY OTHER DRUGS that allow labelling to take care of the issue of slower start time for drug to kick in following a fatty meal: it’s the fatty meal issue not anything about bioequivalence, so far as i know.

Anyway, your message is very disturbing to a longtime investor with a lot of $$$ and high hopes into this. Hopefully we will see high revs and get bought out in the near future. please keep posting.

luvwetscent

07/21/20 2:49 PM

#339177 RE: WeeZuhl #339169

Weez....beautiful.!!!!.....any thoughts on why Hakimus didn't pursue the ER first instead of the IR..that would have validated the two bead..no Tmax issue....but I've been asking that question for years even though i knew the answer.

DR Ryan

07/21/20 4:10 PM

#339188 RE: WeeZuhl #339169

So I take it the tranche of shares for sale at $3 is no longer in play now?

The ELTP King

07/21/20 5:03 PM

#339204 RE: WeeZuhl #339169

Looking forward to this post, hopefully sometime today if possible.

Don't worry, all, Nasrat says he really hopes Elite is able to acquire the Adderall ANDAS some day. More on that to come....




The ELTP King

07/21/20 5:06 PM

#339205 RE: WeeZuhl #339169

Yes, we did.

Nasrat on a 2013 conference call: "That's why I merged my company with Elite."

Didn't we already merge with that company in 2013?